Clotrimazole is an antifungal medication belonging to the azole class. It is commonly supplied as a topical preparation-in this case a 15 g tube of cream or solution-intended for external use. In Hong Kong, clotrimazole-containing products are classified as prescription-only medicines under the Pharmacy and Poisons Ordinance, and they are approved by the Hong Kong Department of Health for the treatment of various superficial fungal infections.
Clotrimazole exerts its antifungal effect by inhibiting the enzyme lanosterol 14α-demethylase, an essential component of the fungal cell membrane synthesis pathway. By blocking this enzyme, clotrimazole prevents the conversion of lanosterol to ergosterol, a sterol that stabilizes fungal cell membranes. Without ergosterol, the membrane becomes permeable, leading to leakage of cellular contents and ultimately fungal cell death. The medication acts locally at the site of application, producing minimal systemic absorption.
Clotrimazole is approved in Hong Kong for the topical treatment of:
These indications reflect its broad activity against common yeasts (Candida spp.) and dermatophytes (Trichophyton, Microsporum).
Current peer-reviewed literature provides limited evidence for off-label uses of topical clotrimazole. Some small studies have explored its role in managing:
These applications are not approved by regulatory agencies in Hong Kong. Off-label use requires medical supervision and individualized risk assessment.
Absolute contraindications
Relative contraindications
Special populations
Topical clotrimazole has a low potential for drug-drug interactions. However:
Routine laboratory monitoring is not required for topical clotrimazole. Patients should schedule a follow-up visit if:
This article provides educational information about clotrimazole and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Topical clotrimazole is generally not recommended for scalp infections because hair impedes adequate contact with the skin. Scalp fungal conditions are usually treated with medicated shampoos or systemic therapy.
In Hong Kong, clotrimazole topical tubes are typically formulated at 1 % (w/w) concentration, providing a standard amount of active drug per gram of cream.
Clotrimazole is classified as Category B; it is considered low risk but should be used only when clearly needed and after discussing with a healthcare professional.
Because clotrimazole is applied topically, systemic interaction with oral antifungals is minimal. However, using multiple topical agents on the same area may increase local absorption.
Occlusive dressings can increase drug absorption and may cause irritation. Use only if specifically directed by a clinician.
Usage varies with the size and number of lesions, but most patients finish a 15 g tube within 2-3 weeks when applying 2-3 times daily.
Topical clotrimazole has limited penetration into the nail plate, making it less effective for onychomycosis. Oral antifungals are usually preferred for nail infections.
Immediately rinse the eye(s) with plenty of clean water for several minutes and seek medical attention promptly.
Diabetic patients may have slower skin healing; they should monitor treated areas for signs of infection or delayed resolution and report concerns to their clinician.
Veterinary formulations of clotrimazole exist, but human products should not be applied to pets without veterinary advice.